Haemonetics | HAE - Ordinary Share Capital


Haemonetics reported $46.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Globus Medical USD 135.06M 449K Dec/2025
Haemonetics USD 46.83M 82K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Intuitive Surgical USD 355.17M 674K Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Neogen USD 217.67M 147K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Quidel USD 67.9M 0 Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
US Physical Therapy USD 15.12M 81.56K Dec/2025
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026